Biosimilars
🇺🇸 FDA Page 3FDA news and analysis for pharmaceutical BD, investment, and market access · 3 articles on this page
Track global biosimilar approvals, market entry strategies, and regulatory pathways. Gain critical intelligence for your pharmaceutical BD and investment decisions.
Showing 25–27 of 27 articles
Earlier
High impact NewsApr 7, 2026
FDA Priority Review Granted to CardioGen's RevivCor for Heart Failure
FDA · Heart Failure · 7 min
Dr. Sarah MitchellHigh impact NewsApr 1, 2026
FDA Approves First Interchangeable Biosimilar for Stelara (Ustekinumab)
FDA · autoimmune diseases · 5 min
Dr. Sarah MitchellCritical impact NewsMar 31, 2026
FDA Approves First Interchangeable Humira Biosimilar: Key Details
FDA · Immunology · 5 min
Dr. Sarah MitchellExplore intelligence